STEP 5: INJECTION & RETRACTION
Bazzano LA, Gu D, Whelton MR, Wu X, Chen CS, Duan X, Chen J, Chen JC, He J
Unlike GLP-1 receptor agonists such as semaglutide (Wegovy) or tirzepatide (Mounjaro), which target hormones released from the gut, cagrilintide works through a completely different pathway
The letter cited products that were "falsely labeled for research purposes or not for human consumption" while being sold directly to consumers with dosing instructions for injection
Shahjouei S, Ansari S, Pourmotabbed T, Zand R
Typical protocols involve doses ranging from 13 mg daily or several times per week, often cycled in 812 week intervals with breaks to prevent receptor downregulation or potential copper accumulation